Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
CancerCalc is an online clinical tool site for oncology professionals, developed by oncology specialists in the UK to support healthcare staff treating cancer patients. It is not a general-purpose developer tool; it is closer to a “clinical calculator platform,” though it does include digital health tools built with web forms and R Shiny.
The platform organizes tools by topics such as Acute Oncology, Breast oncology, CNS oncology, Genetics, GI oncology, Hemato-oncology, and Pharmacology. Its functions cover baseline cardiovascular toxicity risk assessment, immunotherapy toxicity management, RECIST 1.1, TLS risk stratification, ICANS/CRS grading, DPYD activity score, ESMO-MCBS, carboplatin dosing, BSA, opioid conversion, CARG, and more, making it suitable for quick clinical scoring and risk assessment. A more technically distinctive tool is the Kaplan-Meier Digitizer, which allows users to upload KM curve images, extract coordinates, reconstruct curves, and download reconstructed individual patient data. The site notes that this tool is an R Shiny app using the IPDfromKM package.
The captured content does not show any paid plans, subscription prices, payment methods, API, or SDK. The terms grant a non-exclusive, non-transferable license for personal, non-commercial use only, and prohibit copying, selling, licensing, or creating derivative works; therefore, it should not be regarded as an open-source product. There is also no visible information on self-hosting, EMR/EHR integration, batch calls, or developer interfaces.
Its strengths are that the tools cover multiple key scenarios in oncology care, and many pages provide guidelines, research sources, and references, offering relatively good transparency around clinical evidence. Form-based interaction also lowers the barrier to use. The limitations are also clear: the site states that its content is for informational purposes only, does not constitute medical advice, and is not guaranteed to be accurate, up to date, or applicable to specific regions or populations. Information on service support, update frequency, data security, and compliance is also insufficient.
CancerCalc is suitable for oncologists, hematologists, pharmacists, and clinical researchers as an auxiliary calculation and teaching reference tool. It is not suitable for patients making decisions on their own, nor is it appropriate as an automated decision engine within a hospital system. Access from mainland China cannot be determined from the available text, and payment information is also missing. If access or compliance is limited, alternatives may include MDCalc, official NCCN/ESMO materials, eviQ, or locally validated clinical calculators used by hospitals.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on cancercalc.com official site.
cancercalc.com is an Unknown Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach cancercalc.com directly.